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Abstract
AIM: Gastrografin is a hyperosmolar water-soluble contrast
medium. Besides its predictive value for the need for
operative treatment, a potential therapeutic role of this
agent in adhesive small bowel obstruction has been
suggested. This study aimed at evaluating the effectiveness
of gastrografin in adhesive small bowel obstruction when
conservative treatment failed.
METHODS: Patients with adhesive small bowel obstruction
were given trial conservative treatment unless there was
fear of bowel strangulation. Those responded in the initial
48 h had conservative treatment continued.  Patients who
showed no improvement in the initial 48 h were given
100 mL of gastrografin through nasogastric tube followed
by serial abdominal radiographs. Patients with the contrast
appeared in large bowel within 24 h were regarded as
having partial obstruction and conservative treatment was
continued. Patients in which the contrast failed to reach
large bowel within 24 h were considered to have complete
obstruction and laparotomy was performed.
RESULTS: Two hundred and twelve patients with 245
episodes of adhesive obstruction were included. Fifteen
patients were operated on soon after admission due to
fear of strangulation. One hundred and eighty-six episodes
of obstruction showed improvement in the initial 48 h and
conservative treatment was continued. Two patients had
subsequent operations because of persistent obstruction.
Forty-four episodes of obstruction showed no improvement
within 48 h and gastrografin was administered. Seven
patients underwent complete obstruction surgery. Partial
obstruction was demonstrated in 37 other cases, obstruction
resolved subsequently in all of them except one patient
who required laparotomy because of persistent obstruction.
The overall operative rate in this study was 10%. There
was no complication that could be attributed to the use of
gastrografin.
CONCLUSION: The use of gastrografin in adhesive small
bowel obstruction after unsuccessful conservative treatment
is safe and reduces the need for surgical intervention.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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INTRODUCTION
Adhesive small bowel obstruction is one of the most common
surgical causes for admission. More than two-thirds of all
small bowel obstructions were due to peritoneal adhesions[1].
At least 3% of patients after laparotomy developed adhesive
small bowel obstruction. Adhesive obstruction may occur
at any time after surgery, about 20% of the obstructions
appeared more than 10 years after the initial abdominal
operation[2].
Gastrografin (Schering AG, Berlin, Germany), a water-
soluble contrast medium, has been found useful in the
management of adhesive small bowel obstruction. A few
studies reported that gastrografin could accurately predict
the need for surgical treatment[3,4].  Our previous randomized
trial on gastrografin showed that the use of this agent after
unsuccessful conservative treatment markedly reduced the
need for surgery[5]. Since January 2001, we adopted a protocol
of offering gastrografin to patients who failed to respond
to conservative treatment for 48 h. This study aimed at
examining the results of our current management protocol
in adhesive small bowel obstruction.
MATERIALS AND METHODS
Patients over 18 years of age admitted through the emergency
room to the Department of Surgery, University of Hong
Kong Medical Center, Queen Mary’s Hospital with clinical
and radiological evidence of adhesive small bowel obstruction
were included in this study. Patients with early postoperative
obstruction, documented intraabdominal malignancy,
inflammatory bowel disease, or history of abdominal irradiation
were excluded. A detailed history, including information on
previous abdominal surgery and adhesive obstruction, was
taken and a complete physical examination was performed
for every patient. A nasogastric tube was inserted for decom-
pression, with strict measurement of output. Intravenous
fluid replacement was given and electrolyte imbalances were
corrected as required. Supine and erect abdominal radiographs
were taken. Emergency laparotomy was performed for
patients with suspicion of or clinically impending bowel
strangulation. Those without fear of bowel strangulation
were treated conservatively, with close monitoring of  vital
and abdominal signs and daily abdominal radiographs. Patients
with obstruction that improved clinically or radiologically in
the initial 48 h continued to receive conservative treatment.
Clinical improvement was defined as the presence of decreased
abdominal pain, distension, tenderness or nasogastric tube
output, or bowel opening if the patient had constipation on
admission. Radiological improvement was defined as a
decrease in number of dilated bowel loops or in the diameter
of dilated small bowel. Patients who showed neither clinical
nor radiological improvement within 48 h were considered
failed conservative treatment and gastrografin meal and
follow through were performed. The gastrografin study was
performed by a radiologist after an informed consent was
obtained. One hundred milliliters gastrografin were
administered through nasogastric tube, and the transit of
contrast followed by fluoroscopy and serial abdominal
radiographs. Patients in whom the contrast appeared in large
bowel within 24 h were regarded as having partial obstruction.
Conservative treatment was continued for these patients.
If the contrast failed to reach the large bowel within 24 h,
the patient was regarded as having complete obstruction;
these patients were treated with laparotomy. Patients that
showed no progressive clinical and radiological improvement
after 48 h, either in the group of patients who had partial
obstruction demonstrated by gastrografin study or in the
group solely managed by conservative treatment, also
underwent surgery. Complete resolution of bowel obstruction
was established when the symptoms and signs of obstruction
subsided and abdominal radiographs did not show the small
bowel dilated. Complications, death rates, and hospital stays
were recorded. A flow chart illustrating the management
protocol in the study is shown in Figure 1. Data were prosp-
ectively collected and entered into a computer database.
SPSS software (SPSS Inc., Chicago, IL) was used for data
analysis. Univariate analysis was performed by the Student
t test or the Mann-Whitney test for continuous variables
and by Fisher exact tests for categorical variables. P<0.05
was considered statistically significant.
Figure 1  Protocol of study number of cases.
RESULTS
From January 2001 to December 2002, 212 patients (111
men and 101 women) with totally 245 episodes of adhesive
small bowel obstruction were included. The mean age (range)
was 66 (18-97) years. One hundred and forty-nine patients
had single previous abdominal surgery. Colorectal surgery,
cholecystectomy, gynecological surgery and appendectomy
were the most common single antecedent operations. Sixty-
three patients had more than one previous abdominal
operation (Figure 2). Fifty-five patients had a prior history
of adhesive obstruction.
Figure 2  Antecedent operat ions. *Cystectomy Abdominal wall surgery
Nephrectomy Spinal surgery.
The mean duration of symptoms before admission was
1.8 d (range 1-7). Because the duration of nasogastric tube
decompression varied with different patients, the average
nasogastric tube output of each patient (total amount of
drainage/duration) was used for evaluation. For patients
who underwent gastrografin study or surgery, only the output
before the procedure was considered. The mean output
was 23 mL/h (range 0-138).
Fifteen patients had emergency operation performed
within 48 h after admission due to fear of bowel strangulation.
The majority of them were operated on due to clinically
impending bowel strangulation. Laparotomy confirmed
strangulation in one patient and the diseased bowel was
resected. One hundred and eighty-six episodes of obstruction
showed improvement during the initial 48 h, and conservative
treatment was continued. Only two patients required laparotomy
and enterolysis subsequently because of persistent obstruction.
The remaining 184 cases had the bowel obstruction resolved
with conservative treatment; the mean time of  complete
resolution was 56 h (range 5-150) after admission.
Forty-four patients showed no improvement within 48 h.
Gastrografin meal and follow through study was performed
in these 44 patients. The mean time that the study started
was 55 h (range 40-86) after admission. Partial obstruction
was demonstrated in 37 patients. Obstruction resolved
subsequently in 36 patients at a mean time of 49 h (range
8-117) after the administration of gastrografin. The remaining
patient had persistent obstruction after gastrografin study
and required operative treatment. There was no evidence
of bowel strangulation at the time of surgery. Seven patients
had complete obstruction demonstrated by gastrografin
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Conservative treatment
+
study and laparotomy was performed. Strangulation of
bowel was noted in one patient and bowel resection was
required. One patient, who had enterolysis performed after
gastrografin study, developed recurrent small bowel obstruction
due to bezoar and required re-operation. There was otherwise
no complication in the group of patients who were treated
with gastrografin. There was no mortality in this group of
patients.
Comparison of patients with successful and unsuccessful
conservative treatment showed that the nasogastric tube
output was significantly higher in patients who failed to
respond to conservative treatment versus those successfully
treated conservatively (33 mL/h vs 19 mL/h, P = 0.003).
Other variables including sex, age, duration of symptoms
before admission and number of previous abdominal
operations and adhesive small bowel obstruction were not
significantly different between the two groups (Table 1).
DISCUSSION
Adhesive small bowel obstruction is a common surgical
problem, yet there has been no standard protocol for its
management. In the absence of bowel strangulation, adhesive
obstruction can be treated conservatively. However, the
optimal duration of  this trial conservative treatment is
controversial. There is no definite answer as to when
conservative treatment should be considered unsuccessful
and operative treatment should be performed.
In a retrospective study, Cox et al, reported that 69%
of adhesive obstructions resolved by conservative treatment.
Among the cases that had successful conservative treatment,
88% resolved within 48 h[6]. In another study by Sosa et al,
a 35% failure rate of non-operative treatment was reported.
It was also found that significant complications occurred in
those patients with surgery delayed for more than 48 h[7].
Based on the results of these studies, it is reasonable to
recommend that adhesive small bowel obstruction can be
managed conservatively for 48 h, surgical treatment should
be offered promptly if there is no improvement within this
time period.
The use of gastrografin in the management of adhesive
small bowel obstruction has been evaluated in recent years.
Gastrografin is a water-soluble contrast medium composed
of sodium diatrizoate, meglumine amidotriozoate and a
wetting agent (polysorbate 80). It has an osmolarity of
1 900 mOsm/L, which is approximately six times that of
extracellular fluid. In Onoue et al’s study, Gastrografin was
given to patients with adhesive obstruction on admission.
Of those who had the contrast medium appeared in the
colon within 24 h, 98% had the obstruction resolved by
conservative treatment. On the other hand, 80% of  patients
who failed to have the contrast medium shown in the colon
within 24 h required operative treatment[3]. Chen et al, have
performed a similar study in which another water-soluble
contrast medium, Urografin (Schering AG, Berlin, Germany),
was used. Urografin has essentially the same composition
as that of gastrografin. The main difference between the
two agents is that urografin has a lower osmolarity. Similar
results were obtained, indeed, the predictive value of water-
soluble contrast medium for the need of operative treatment
was even higher in the latter study[4].
Gastrografin may also have a therapeutic effect in adhesive
small bowel obstruction. Because of its hyperosmolarity,
Gastrografin promotes shifting of fluid into bowel lumen
and increases the pressure gradient across an obstructive
site. The bowel content is diluted and in the presence of
the wetting agent, easier passage of bowel content through
a narrowed lumen may be allowed. Gastrografin also
decreases edema of bowel wall and enhances bowel motility.
In a randomized controlled study performed by Assalia
et al, about 100 mL of Gastrografin was given on admission
to patients in the study group. A significant reduction in the
need for operative treatment in the study group was reported[8].
The results of our previous randomized trial also supported
a therapeutic role of Gastrografin in adhesive obstruction.
Patients who showed neither clinical nor radiologic improvement
in the initial 48 h were considered to have conservative
treatment failed and underwent either Gastrografin study
or surgery. The need for operative treatment was markedly
reduced by 74% in the Gastrografin group[5]. Since then it
has become our routine to use Gastrografin for patients
with failure of  conservative treatment.
The administration of Gastrografin in adhesive small bowel
obstruction is safe even after unsuccessful conservative
treatment. There was no complication or mortality that could
be attributed to the use of Gastrografin in the present study.
In fact, adverse effects due to the use of Gastrografin in
small bowel obstruction have rarely been reported. A
potential complication of using Gastrografin in the presence
of bowel obstruction is aspiration pneumonia. In our
management protocol, Gastrografin was only given after
48 h of  conservative treatment. By the time that the contrast
medium was administered, the stomach should have been
adequately decompressed through nasogastric tube and
therefore the risk of aspiration pneumonia minimized.
Another potential adverse effect of Gastrografin is that it
may further dehydrate a patient with small bowel obstruction
because of the shifting of fluid into bowel lumen. The
practise of giving Gastrografin at 48 h may also reduce the
risk of this adverse phenomenon because the patients should
Table 1  Successful vs unsuccessful conservative treatment
Successful conservative Gastrografin    P
     treatment n = 184         n = 46
Sex (M/F)                  102/82        19/27 0.09
Age (mean)               18-97 (67)    31-92 (65) 0.56
Number of operation (mean)                 1-5 (1.4)     1-3 (1.5) 0.47
Numberof obstruction (mean)                 0-5 (0.41)     0-4 (0.6) 0.28
Duration of symptoms (mean)                1-7 (1.8) d                      1-5 (1.8) d 0.95
Nasogastric tube output (mean)          0-80 (19) mL/h                  5-87 (33) mL/h 0.003
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have been adequately rehydrated prior to the administration
of Gastrografin.
The incidence of bowel strangulation in patients with
adhesive small bowel obstruction ranged from 6% to 11%
in previous reports[9-11]. In our study, the overall strangulation
rate was 0.8%. Among the 44 patients who had Gastrografin
given after unsuccessful conservative treatment, only one
patient suffered from strangulation of bowel. There was
no evidence that the use of Gastrografin would increase
the risk of bowel strangulation.
Surgery was required in 27-35% of patients with adhesive
small bowel obstruction according to previous retrospective
studies[6,7,10,11]. The overall need for surgical treatment was
10% under our management protocol. To our knowledge,
we have achieved the lowest operative rate for adhesive small
bowel obstruction in the literature. If we had not used
gastrografin, all the 44 cases which showed no improvement
in the initial 48 h would have had to be operated on and the
overall operative rate in our series would have increased to
25%. We conclude that the use of  gastrografin in adhesive
small bowel obstruction after unsuccessful conservative
treatment is safe and reduces the need for operative treatment.
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